Early Experiences with Stem Cells in Treating Chronic Wounds

Clinics in Plastic Surgery

Volumn 39, Issue 3, 2012, Pages 281-292

  Akita, Sadanori ^a   Yoshimoto, Hiroshi ^a   Akino, Kozo ^a   Ohtsuru, Akira ^b,c   Hayashida, Kenji ^a   Hirano, Akiyoshi ^a   Suzuki, Keiji ^d   Yamashita, Shunichi ^b,c,d  

^a Department of Plastic and Reconstructive Surgery ^*  (Japan)

^b NAGASAKI UNIVERSITY HOSPITAL   (Japan)

^c FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

^d NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Adipose derived stem cell therapy for local chronic radiation injury; Clinical study; Nagasaki

Indexed keywords

ADIPOSE DERIVED STEM CELL; CHRONIC WOUND; HUMAN; NONHUMAN; PATHOGENESIS; PATIENT IDENTIFICATION; PATIENT SELECTION; RADIATION HAZARD; RADIATION INJURY; REGENERATIVE MEDICINE; REVIEW; RISK REDUCTION; STEM CELL TRANSPLANTATION; SURGICAL TECHNIQUE; TREATMENT OUTCOME; WOUND HEALING IMPAIRMENT;

ADIPOSE TISSUE; BANDAGES; CHRONIC DISEASE; DEBRIDEMENT; DIABETIC FOOT; HUMANS; MALE; MIDDLE AGED; PRESSURE ULCER; RADIATION INJURIES; SKIN; STEM CELL TRANSPLANTATION; SURGICAL FLAPS; VARICOSE ULCER; WOUND HEALING; WOUNDS AND INJURIES;

EID: 84862728176     PISSN: 00941298     EISSN: 15580504     Source Type: Journal    
DOI: 10.1016/j.cps.2012.04.005     Document Type: Review

References (70)

1. Martin P. Wound healing-aiming for perfect skin regeneration. Science 1997, 276:75-81.
2. Brem H., Tomic-Canic M. Cellular and molecular basis of wound healing in diabetes. J Clin Invest 2007, 117:1219-1222.
3. Mustoe T., O'Shaughnessy K., Kloeters O. Chronic wound pathogenesis and current treatment strategies: a unifying hypothesis. Plast Reconstr Surg 2006, 117(Suppl 7):S35-S41.
4. Hanjaya-Putra D., Gerecht S. Vascular engineering using human embryonic stem cells. Biotechnol Prog 2009, 25:2-9.
5. Sorrell J., Baber M., Caplan A. Influence of adult mesenchymal stem cells on in vitro vascular formation. Tissue Eng Part A 2009, 15:1751-1761.
6. Wu Q., Shao H., Darwin E.D., et al. Extracellular calcium increases CXCR4 expression on bone marrow-derived cells and enhances pro-angiogenesis therapy. J Cell Mol Med 2009, 13:3764-3773.
7. Watkins S., Zippin J. When wound healing goes awry. A review of normal and abnormal wound healing, scar pathophysiology and therapeutics. J Drugs Dermatol 2008, 7:997-1005.
8. Heit J., Rooke T., Silverstein M., et al. Trends in the incidence of venous stasis syndrome and venous ulcer: a 25-year population-based study. J Vasc Surg 2001, 33:1022-1027.
9. Rogers A., Burnett S., Moore J., et al. Involvement of proteolytic enzymes-plasminogen activators and matrix metalloproteinases-in the pathophysiology of pressure ulcers. Wound Repair Regen 1995, 3:273-283.
10. Boulton A.J. The diabetic foot: a global view. Diabetes Metab Res Rev 2000, 16(Suppl 1):S2-S5.
11. Gershater M.A., Londahl M., Nyberg P., et al. Complexity of factors related to outcome of neuropathic and neuroischaemic/ischaemic diabetic foot ulcers: a cohort study. Diabetologia 2009, 52:398-407.
12. Mogford J.E., Liu W.R., Reid R., et al. Adenoviral human telomerase reverse transcriptase dramatically improves ischemic wound healing without detrimental immune response in an aged rabbit model. Hum Gene Ther 2006, 17:651-660.
13. Kubiak B.D., Albert S.P., Gatto A.L., et al. Peritoneal negative pressure therapy prevents multiple organ injury in a chronic porcine sepsis and ischemia/reperfusion model. Shock 2010, 34:525-534.
14. Schultz G.S., Sibbald R.G., Falanga V., et al. Wound bed preparation: a systemic approach to wound management. Wound Repair Regen 2003, 11:S1-S28.
15. Nedeau A.E., Gallagher K.A., Liu Z.J., et al. Elevation of hemopexin-like fragment of matrix metalloproteinase-2 tissue levels inhibits ischemic wound healing and angiogenesis. J Vasc Surg 2011, 54:1430-1438.
16. Hamed S., Ulmann Y., Egozi D., et al. Fibronectin potentiates topical erythropoietin-induced wound repair in diabetic mice. J Invest Dermatol 2011, 131:1365-1374.
17. Kao H.K., Chen B., Murphy G.F., et al. Peripheral blood fibrocytes: enhancement of wound healing by cell proliferation, re-epithelialization, contraction, and angiogenesis. Ann Surg 2011, 254:1066-1074.
18. Ligresiti C., Bo F. Wound bed preparation of difficult wounds: an evolution of the principles of TIME. Int Wound J 2007, 4:21-29.
19. Macri L., Clark R.A. Tissue engineering for cutaneous wounds: selecting the proper time and space for growth factors, cells and the extracellular matrix. Skin Pharmacol Physiol 2009, 22:83-93.
20. Smiell J.M., Wieman T.J., Steed D.L., et al. Efficacy and safety of becaplermin (recombinant human platelet-derived growth factor-BB) in patients with nonhealing, lower extremity diabetic ulcers: a combined analysis of four randomized studies. Wound Repair Regen 1998, 7:335-346.
21. Robson M.C., Phillips L.G., Lawrence W.T., et al. The safety and effect of topically applied recombinant basic fibroblast growth factor on healing of chronic pressure sores. Ann Surg 1992, 216:401-416.
22. Marston W.A., Hanft J., Norwood P., et al. The efficacy and safety of Dermagraft in improving the healing of chronic diabetic foot ulcers: results of a prospective randomized trial. Diabetes Care 2003, 26:1701-1705.
23. Falanga V., Sabolinksi M. A bilayered living skin construct (APLIGRAF) accelerates complete closure of hard-to-heal venous ulcers. Wound Repair Regen 1999, 7:201-207.
24. Anderson D.J., Gage F.H., Weissman I.L. Can stem cells cross lineage boundaries?. Nat Med 2001, 7:393-395.
25. Montanucci P., Basta G., Pescara T., et al. New simple and rapid method for purification of mesenchymal stem cells from the human umbilical cord Wharton jelly. Tissue Eng Part A 2011, 17:2651-2661.
26. Pittenger M.F., McKay S.C., Beck R.K., et al. Multi-lineage potential of adult human mesenchymal stem cells. Science 1999, 284:143-147.
27. da Silva Meirelles L., Chagastelles P.C., Nardi N.B. Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J Cell Sci 2006, 119(Pt 11):2204-2213.
28. Krause D.S., Theise N.D., Collector M.I., et al. Multi-organ, multilineage engraftment by a single bone marrow-derived stem cell. Cell 2001, 105:369-377.
29. Badiavas E.V., Abedi M., Butmarc J., et al. Participation of bone marrow derived cells in cutaneous wound healing. J Cell Physiol 2003, 196:245-250.
30. Barry F.P., Murphy J.M. Mesenchymal stem cells: clinical applications and biological characterization. Int J Cell Biol 2004, 36:568-584.
31. Akita S., Akino K., Hirano A., et al. Mesenchymal stem cell therapy for cutaneous radiation syndrome. Health Phys 2010, 98:858-862.
32. Ning H., Lin G., Lue T.F., et al. Mesenchymal stem cell marker Stro-1 is a 75kd endothelial antigen. Biochem Biophys Res Commun 2011, 413:353-357.
33. Han S.K., Yoon T.H., Lee D.G., et al. Potential of human bone marrow stromal cells to accelerate wound healing in vitro. Ann Plast Surg 2005, 55:414-419.
34. Nakagawa H., Akita S., Fukui M., et al. Human mesenchymal stem cells successfully improve skin-substitute wound healing. Br J Dermatol 2005, 153:29-36.
35. Badiavas E.V., Falanga V. Treatment of chronic wounds with bone marrow-derived cells. Arch Dermatol 2003, 139:510-516.
36. Falanga V., Iwamoto S., Chartier M., et al. Autologous bone marrow-derived cultured mesenchymal stem cells delivered in a fibrin spray accelerates healing in murine and human cutaneous wounds. Tissue Eng 2007, 13:1299-1312.
37. Lataillade J.J., Doucet C., Bey E., et al. New approach to radiation burn treatment by dosimetry-guided surgery combined with autologous mesenchymal stem cell therapy. Regen Med 2007, 2:785-794.
38. Yoshikawa T., Mitsuno H., Nonaka I., et al. Wound therapy by marrow mesenchymal cell transplantation. Plast Reconstr Surg 2008, 121:860-877.
39. Wu Y., Chen L., Scott P.G., et al. Mesenchymal stem cells enhance wound healing through differentiation and angiogenesis. Stem Cells 2007, 25:2648-2659.
40. Kwon D.S., Gao X., Liu Y.B., et al. Treatment with bone marrow-derived stromal cells accelerates wound healing in diabetic rats. Int Wound J 2008, 5:453-463.
41. Sasaki M., Abe R., Fujita Y., et al. Mesenchymal stem cells are recruited into wounded skin and contribute to wound repair by transdifferentiation into multiple skin cell type. J Immunol 2008, 180:2581-2587.
42. Ren H., Cao Y., Zhao Q., et al. Proliferation and differentiation of bone marrow stromal cells under hypoxic conditions. Biochem Biophys Res Commun 2006, 347:12-21.
43. Stoff A., Rivera A.A., Sanjib Banerjee N., et al. Promotion of incisional wound repair by human mesenchymal stem cell transplantation. Exp Dermatol 2009, 18:362-369.
44. McFarlin K., Gao X., Liu Y.B., et al. Bone marrow-derived mesenchymal stromal cells accelerates wound healing in the rat. Wound Repair Regen 2006, 14:471-478.
45. Mori L., Bellini A., Stacey M.A., et al. Fibrocytes contribute to the myofibroblast population in wounded skin and originate from the bone marrow. Exp Cell Res 2005, 304:81-90.
46. Bucala R., Spiegel L.A., Chesney J., et al. Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair. Mol Med 1994, 1:71-81.
47. Kim W.S., Park B.S., Sung J.H., et al. Wound healing effect of adipose-derived stem cells: a critical role of secretory factors on human dermal fibroblasts. J Dermatol Sci 2007, 48:15-24.
48. Zuk P.A., Zhu M., Mizuno H., et al. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng 2001, 7:21-28.
49. Zuk P.A., Zhu M., Ashjian P., et al. Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 2002, 13:4279-4295.
50. Kondo K., Shintani S., Shibata R., et al. Implantation of adipose-derived regenerative cells enhances ischemia-induced angiogenesis. Arterioscler Thromb Vasc Biol 2009, 29:61-66.
51. Giorgino F., Laviola L., Eriksson J.W. Regional differences of insulin action in adipose tissue: insights from in vivo and in vitro studies. Acta Physiol Scand 2005, 183:13-30.
52. Schipper B.M., Marra K.G., Zhang W., et al. Regional anatomic and age effects on cell function of human adipose-derived stem cells. Ann Plast Surg 2008, 60:538-544.
53. Strem B.M., Hicok K.C., Zhu M., et al. Multipotential differentiation of adipose tissue-derived stem cells. Keio J Med 2005, 54:132-141.
54. von Heimburgh D., Hemmrich K., Haydarlioglu S., et al. Comparison of viable cell yield form excised versus aspirated adipose tissue. Cells Tissues Organs 2004, 178:87-92.
55. Tholpady S.S., Aojanepong C., Llull R., et al. The cellular plasticity of human adipocytes. Ann Plast Surg 2005, 54:651-656.
56. Nie C., Yang D., Xu J., et al. Locally administered adipose-derived stem cells accelerate wound healing through differentiation and vasculogenesis. Cell Transplant 2011, 20:205-216.
57. Strem B.M., Hedrick M.H. The growing importance of fat in regenerative medicine. Trends Biotechnol 2005, 23:64-66.
58. Neofytou E.A., Chang E., Patlola B., et al. Adipose tissue-derived stem cells display a proangiogenic phenotype on 3D scaffolds. J Biomed Mater Res A 2011, 98:383-393.
59. Roche S., Delorme B., Oostendorp R.A., et al. Comparative proteomic analysis of human mesenchymal and embryonic stem cells: towards the definition of a mesenchymal stem cell proteomic structure. Proteomics 2009, 9:232-233.
60. Ebrahimian T.G., Pouzoulet F., Squiban C., et al. Cell theory based on adipose tissue-derived stromal cells promotes physiological and pathological wound healing. Arterioscler Thromb Vasc Biol 2009, 29:503-510.
61. Nie C., Yang D., Morris S.F. Local delivery of adipose-derived stem cells via acellular dermal matrix as a scaffold: a new promising strategy to accelerate wound healing. Med Hypotheses 2009, 72:679-682.
62. Trottier V., Marceau-Fortier G., Germain L., et al. IFATS collection: Using human adipose-derived stem/stromal cells for the production of new skin substitutes. Stem Cells 2008, 26:2713-2723.
63. Altman A.M., Matthias N., Yan Y., et al. Dermal matrix as a carrier for in vivo delivery of human adipose-derived stem cells. Biomaterials 2008, 29:1431-1442.
64. Nambu M., Kishimoto S., Muzuno H., et al. Accelerated wound healing in healing-impaired db/db mice by autologous adipose tissue-derived stromal cells combined with atelocollagen matrix. Ann Plast Surg 2009, 62:317-321.
65. Blanton M., Hadad I., Johnstone B., et al. Adipose stromal cells and platelet-rich plasma therapies synergistically increase revascularization during wound healing. Plast Reconsr Surg 2009, 123(Suppl 2):56S-64S.
66. Kim W.S., Park B.S., Sung J.H. The wound-healing and antioxidant effects of adipose-derived stem cells. Expert Opin Biol Tjer 2009, 9:879-887.
67. Lee E.Y., Xia Y., Kim W.S., et al. Hypoxia-enhanced wound-healing function of adipose-derived stem cells: increase in stem cell proliferation and upregulation of VEGF and bFGF. Wound Repair Regen 2009, 17:540-547.
68. Bey E., Prat M., Duhamel P., et al. Emerging therapy for improving wound repair of severe radiation burns using local bone marrow-derived stem cell administrations. Wound Repair Regen 2010, 18:50-58.
69. Rigotti G., Marchi A., Galie M., et al. Clinical treatment of radiotherapy tissue damage by lipoaspirate transplant: a healing process mediated by adipose-derived adult stem cells. Plast Reconostr Surg 2007, 119:1409-1422.
70. Akita S., Akino K., Hirano A., et al. Noncultured autologous adipose-derived stem cells therapy for chronic radiation injury. Stem Cells Int 2010, 2010:52704.